Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
November 17, 2022 - Fresenius launched an authorized brand alternative (ABA) of Acrotech Biopharma’s Folotyn (pralatrexate) injection.
Download PDF
Return to publications
